Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Mast Therapeutics Inc (NYSE MKT LLC:MSTX)

0.3361
Delayed Data
As of May 27
 -0.0039 / -1.15%
Today’s Change
0.21
Today|||52-Week Range
0.60
-20.03%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2015
Quarter 3
2015
Quarter 4
2015
Quarter 1
2016
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization37.0K38.0K41.0K32.0K
 
 
 
 
 
 
Operating ExpensesGross Income-37.0K-38.0K-41.0K-32.0K
 
 
 
 
 
General Expenses10.1M9.8M9.7M10.7M
 
 
 
 
 
Research And Development7.7M7.3M7.2M7.9M
 
 
 
 
 
Total Operating Expenses10.2M9.8M9.7M10.7M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-10.2M-9.8M-9.7M-10.7M
 
 
 
 
 
Interest Expense On Debt1.0K101.0K501.0K519.0K
 
 
 
 
 
Other Expenses-1.0K-15.0K16.0K15.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-10.2M-9.9M-10.2M-11.2M
 
 
 
 
 
Net Income-10.2M-9.9M-10.2M-11.2M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS162.1M163.6M163.6M178.1M
 
 
 
 
 
Shares To Calculate EPS Diluted162.1M163.6M163.6M178.1M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.06-$0.06-$0.06-$0.06
 
 
 
 
 
EPS Diluted-$0.06-$0.06-$0.06-$0.06